Nautilus Biotechnology Inc logo

NAUT

Nautilus Biotechnology Inc

$2.72

Earnings Summary

Revenue
$0Mn
Net Profits
$-15.88Mn
Net Profit Margins
-Inf%

Highlights

Revenue:

Nautilus Biotechnology Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2023. On a quarterly growth basis, Nautilus Biotechnology Inc has generated NaN% jump in its revenue since last 3-months.

Net Profits:

Nautilus Biotechnology Inc’s net profit jumped 0.46% since last year same period to $-15.88Mn in the Q3 2023. On a quarterly growth basis, Nautilus Biotechnology Inc has generated -0.44% fall in its net profits since last 3-months.

Net Profit Margins:

Nautilus Biotechnology Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q3 2023. On a quarterly growth basis, Nautilus Biotechnology Inc has generated NaN% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Nautilus Biotechnology Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.3
EPS Estimate Current Year
-0.3

Highlights

EPS Estimate Current Quarter:

Nautilus Biotechnology Inc’s earning per share (EPS) estimates for the current quarter stand at -0.3 - a -112.5% fall from last quarter’s estimates.

EPS Estimate Current Year:

Nautilus Biotechnology Inc’s earning per share (EPS) estimates for the current year stand at -0.3.

Key Ratios

Key ratios of the Nautilus Biotechnology Inc post its Q3 2023 earnings

Earning Per Share (EPS)
-0.13
Return on Assets (ROA)
-0.13
Return on Equity (ROE)
-0.2

Highlights

Earning Per Share (EPS):

Nautilus Biotechnology Inc’s earning per share (EPS) fell -18.18% since last year same period to -0.13 in the Q3 2023. This indicates that the Nautilus Biotechnology Inc has generated -18.18% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Nautilus Biotechnology Inc’s return on assets (ROA) stands at -0.13.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Nautilus Biotechnology Inc’s return on equity (ROE) stands at -0.2.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2023-08-02
-0.15
-0.13
13.33%
2023-05-02
-0.17
-0.12
29.41%
2023-10-31
-0.17
-0.13
23.53%